PGN Pgnx Capital Corporation

Martin Weinberg, Chairman of the Board of Directors of Paragon Pharmacies
Limited (TSX VENTURE:PGN) ("Paragon" or "the Company") announced today the
appointment of Robert (Gordon) Gooding, CA, as the Chief Executive Officer for
the Company. 


This appointment, which is effective April 1, 2010, is the culmination of an
extensive search process that began in August 2009 upon the departure of the
previous President. 


Mr. Weinberg says, "Gordon brings extensive experience in the retail sector
having served as CEO, President and Chief Financial Officer of a U.S. retail
organization he established and grew to a 50-store chain. Gordon's knowledge in
merchandising and general management together with his financial background will
provide the leadership necessary to allow Paragon to move forward on its goal to
be the premier mid-market community-based pharmacy."


The Board of Directors also thanks Denis Taillieu for his leadership and
guidance as acting Chief Executive Officer during the search period. Mr.
Taillieu also served as interim CFO prior to taking on duties as CEO. Mr.
Taillieu is also a member of the Board of Directors and Audit Committee and will
continue in this capacity while, at the same time, ensuring a smooth transition
as Mr. Gooding assumes his new role.


Paragon Pharmacies Limited is building a pharmacy with our customers in mind.
Headquartered in Kelowna, BC and employing over 400 staff, Paragon currently
owns and operates 19 retail pharmacies and three central fill pharmacies
throughout British Columbia, Alberta and Manitoba. Paragon is a leading
mid-market pharmacy, providing premier pharmacy services in a friendly,
community-focused environment.


FORWARD LOOKING STATEMENTS

This press release contains forward-looking statements regarding, among other
things, the Company's beliefs, plans, objectives, strategies, estimates,
intentions and expectations, including as they relate to its operating and
financial results, capital expenditures and the ability to execute on its
operating, investing and financing strategies. Consequently, actual results and
events may differ materially from those included in, contemplated or implied by
such forward looking statements for a variety of reasons. Forward-looking
statements are subject to inherent risks and uncertainties including, but not
limited to, market and general economic conditions, certain property and
casualty risks, the ability to attract and retain pharmacists, the availability
and terms of financing, changes in the Company's relationship with its key
suppliers, competitive factors, changes in regulatory environments affecting the
Company's business, and the accuracy in management's assumptions (see "RISKS AND
RISK MANAGEMENT" as noted in the Company's Management's Discussion & Analysis
posted on SEDAR at www.sedar.com). This list is not exhaustive of the factors
that may affect any of the Company's forward-looking statements. Investors and
others should carefully consider these and other factors and not place undue
reliance on these forward-looking statements. In addition, these forward-looking
statements relate to the date on which they were made and the Company disclaims
and has no intention or obligation to update or revise any forward-looking
statement, whether as a result of new information, future events or otherwise.

Pgnx Capital Corporation (TSXV:PGN)
Historical Stock Chart
From Apr 2024 to May 2024

Pgnx Capital Corporation (TSXV:PGN)
Historical Stock Chart
From May 2023 to May 2024